Similarly, another study focused on hypoxia-regulated ferroptosis in HCC cells and pinpointed the HIF-1α/METTL14/YTHDF2/SLC7A11 axis as a potential therapeutic target for HCC interventional embolization treatment 70. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.